エボラス
Evolus, Inc.
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorporated in 2012 and is headquartered in Newport Beach, California.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q1 | -0.16 | $73M | -$10M |
| 2025 Q4 | 0.00 | $90M | $11M |
| 2025 Q3 | -0.24 | $69M | -$17M |
| 2025 Q2 | -0.27 | $69M | -$25M |
| 2025 Q1 | -0.30 | $69M | -$17M |
| 2024 Q4 | -0.11 | $79M | $3M |
| 2024 Q3 |
| -0.30 |
| $61M |
| -$7M |
| 2024 Q2 | -0.18 | $67M | -$8M |